Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 19/20 | 0.53 |
| ▸ | CYP11B1 | P15538 | 17/20 | 0.52 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26695759 | 1.00 | CYP11B2 (0.53) | CYP11B2CYP11B1KDM1A | |
| SCHEMBL16797298 | 0.86 | CYP11B2 (0.51) | CYP11B2CYP11B1KDM1A | |
| SCHEMBL30036996 | 0.78 | KCNQ3 (0.42) | — | |
| SCHEMBL25551797 | 0.78 | KCNQ3 (0.42) | — | |
| SCHEMBL26695686 | 0.76 | KDM1A (0.60) | KDM1A | |
| SCHEMBL31280612 | 0.76 | KDM1A (0.60) | KDM1A | |
| SCHEMBL3753115 | 0.75 | CYP11B2 (0.58) | CYP11B2CYP11B1 | |
| SCHEMBL29998142 | 0.75 | CYP11B2 (0.58) | CYP11B2CYP11B1 | |
| SCHEMBL16797309 | 0.75 | KDM1A (0.49) | CYP11B2KDM1A | |
| SCHEMBL22544473 | 0.73 | AAK1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304549-A1 | HYDROXYAMIDE DERIVATIVE AND USE THEREOF | SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) | 2025-10-02 | — | — | US | disclosed |
| EP-4509500-A1 | HYDROXYAMIDE DERIVATIVE AND USE THEREOF | Sichuan Huiyu Pharmaceutical Co., Ltd. (CN) | 2025-02-19 | — | — | EP | disclosed |
| CN-119173510-A | Hydroxy amide derivative and application thereof | 四川汇宇制药股份有限公司 | 2024-12-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304549-A1 | HYDROXYAMIDE DERIVATIVE AND USE THEREOF | HDAC1, HDAC11, HDAC5 | CYP11B2 109/4885CYP11B1 135/4885KDM1A 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.